The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function
Richard J. Knight, Ronald H. Kerman, Linda Schoenberg, Hemangshu Podder, Charles T. Van Buren, Stephen Katz, Barry D. Kahan
Dive into the research topics of 'The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science